| Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold C Crowley, P Klanrit, CR Butler, A Varanou, M Platé, RE Hynds, ... Biomaterials 83, 283-293, 2016 | 64 | 2016 |
| Role of nanotechnology in development of artificial organs GZ Teoh, P Klanrit, M Kasimatis, AM Seifalian Minerva medica 106, 17-33, 2015 | 23 | 2015 |
| Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples W Taron, K Phooplub, S Sanchimplee, K Piyanamvanich, W Jamnongkan, ... Sensors and Actuators B: Chemical 348, 130705, 2021 | 21 | 2021 |
| Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma S Padthaisong, M Thanee, N Namwat, J Phetcharaburanin, P Klanrit, ... Journal of translational medicine 18, 1-17, 2020 | 21 | 2020 |
| Targeting fatty acid synthase modulates metabolic pathways and inhibits cholangiocarcinoma cell progression J Tomacha, H Dokduang, S Padthaisong, N Namwat, P Klanrit, ... Frontiers in Pharmacology 12, 696961, 2021 | 19 | 2021 |
| Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway S Khophai, M Thanee, A Techasen, N Namwat, P Klanrit, A Titapun, ... OncoTargets and therapy, 7019-7029, 2018 | 18 | 2018 |
| Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models M Thanee, S Padthaisong, M Suksawat, H Dokduang, ... Cancer & Metabolism 9, 1-13, 2021 | 14 | 2021 |
| Opposing roles of FoxA1 and FoxA3 in intrahepatic cholangiocarcinoma progression R Thanan, W Kaewlert, C Sakonsinsiri, T Chaiprasert, N Armartmuntree, ... International Journal of Molecular Sciences 21 (5), 1796, 2020 | 14 | 2020 |
| Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage … S Padthaisong, J Phetcharaburanin, P Klanrit, JV Li, N Namwat, ... Cancer & Metabolism 9, 1-15, 2021 | 13 | 2021 |
| A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma S Padthaisong, M Thanee, N Namwat, J Phetcharaburanin, P Klanrit, ... BMC cancer 20, 1-16, 2020 | 13 | 2020 |
| In vitro and in vivo anti-tumor effects of pan-HER inhibitor varlitinib on cholangiocarcinoma cell lines H Dokduang, W Jamnongkarn, B Promraksa, M Suksawat, S Padthaisong, ... Drug Design, Development and Therapy, 2319-2334, 2020 | 12 | 2020 |
| A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples W Taron, W Jamnongkan, J Phetcharaburanin, P Klanrit, N Namwat, ... Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 254, 119633, 2021 | 11 | 2021 |
| CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression M Thanee, H Dokduang, Y Kittirat, J Phetcharaburanin, P Klanrit, ... PloS one 16 (3), e0245871, 2021 | 9 | 2021 |
| In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues M Suksawat, P Klanrit, J Phetcharaburanin, N Namwat, N Khuntikeo, ... PLoS One 14 (9), e0222140, 2019 | 9 | 2019 |
| Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits PN Ho, P Klanrit, Y Hanboonsong, U Yordpratum, M Suksawat, ... Scientific Reports 11 (1), 23316, 2021 | 8 | 2021 |
| Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma Y Kittirat, M Suksawat, S Thongchot, S Padthaisong, J Phetcharaburanin, ... Frontiers in Pharmacology 13, 897368, 2022 | 6 | 2022 |
| Antioxidant and Anticancer Potential of Bioactive Compounds from Rhinacanthus nasutus Cell Suspension Culture P Songserm, P Klanrit, P Klanrit, J Phetcharaburanin, P Thanonkeo, ... Plants 11 (15), 1994, 2022 | 6 | 2022 |
| Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway S Janthamala, A Jusakul, S Kongpetch, P Kimawaha, P Klanrit, ... Naunyn-Schmiedeberg's Archives of Pharmacology 394, 2049-2059, 2021 | 6 | 2021 |
| 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination J Phetcharaburanin, S Deewai, T Kulthawatsiri, K Moolpia, M Suksawat, ... Plos one 15 (12), e0243432, 2020 | 6 | 2020 |
| Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies JH Hong, CH Yong, HL Heng, JY Chan, MC Lau, J Chen, JY Lee, AH Lim, ... Gut, 2023 | 5 | 2023 |
